Newsfeed

Bei diesem Bereich handelt es sich um eine mögliche Darstellungsform der Integration von Nachrichtenquellen mit Bezug zu börsennotierten Unternehmen.
Als Präsentationsebene fungiert ein Template, dass an Kurznachrichtenservices angelehnt ist, bei dem sich Nutzer einen schnellen Überblick über aktuelle Nachrichten verschaffen können. Die Detailansichten ermöglichen bei Interesse weitergehende Recherchen.

Dieser Newsfeed ist eine Zusammenstellung aktueller Nachrichten, die aus Direktanbindungen von TopTier NewsWire-Services mit Bezug zu börsennotierten Unternehmen stammen. Dieser Feed hier dient ausschließlich Demonstrationszwecken. Sektoren-spezifische Nachrichten, Public Relations sowie Produktinformationen können über die GICS Portale > Bereich Sektor-Intelligence abgerufen werden.

US08659B1026
Filter zurücksetzen
Do you already know our new terminal view? Click here.
FIGI: BBG00JNGG9Q2
BBNX

Beta Bionics, Inc.
GICS: Health Care · SECTOR: EQTY · SUB-SECTOR: - · THEMEFOLIO: $HLTH
NAME
Beta Bionics, Inc.
ISIN
US08659B1026
TICKER
BBNX
MIC
XNAS
REUTERS
BBNX.OQ
BLOOMBERG
BBNX US
Di., 03.11.2026       Beta Bionics

NEW YORK, Nov. 3, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Beta Bionics, Inc. (NASDAQ: BBNX) between July 30, 2025 and February 24, 2026, both dates inclusive (the "Class Period"), of the important November 3,...
Di., 03.11.2026       Beta Bionics

Rosen Law Firm, a global investor rights law firm, reminds investors about a class action on behalf of purchasers of common stock of Beta Bionics, Inc. (NASDAQ: BBNX) between July 30, 2025 and February 24, 2026. Beta Bionics describes itself as a “commercial-stage medical device company that offers an automated insulin delivery system for the treat...
Di., 03.11.2026       Beta Bionics

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Beta Bionics, Inc. (“Beta Bionics” or the “Company”) (NASDAQ: BBNX) and reminds investors of the November 3, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. This...
Di., 03.11.2026       Beta Bionics

IRVINE, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that management will participate at upcoming investor conferences:...
Di., 03.11.2026       Beta Bionics

New York, New York--(Newsfile Corp. - November 2, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Beta Bionics, Inc. (NASDAQ: BBNX) between July 30, 2025 and February 24, 2026, both dates inclusive (the "Class Period"), of the important November 3, 2026 lead plaintiff deadline.SO WHAT: If you pu...
Mo., 02.11.2026       Beta Bionics

San Francisco, California--(Newsfile Corp. - November 2, 2026) - Hagens Berman reminds investors in Beta Bionics, Inc. (NASDAQ: BBNX) of the pending securities class action lawsuit and upcoming November 3, 2026 lead plaintiff deadline under the Private Securities Litigation Reform Act (PSLRA).Investors who suffered substantial losses purchasing Bet...
Mo., 02.11.2026       Beta Bionics

Philadelphia, Pennsylvania--(Newsfile Corp. - November 2, 2026) - Berger Montague PC, a leading national plaintiffs' law firm, announces a class action lawsuit against Beta Bionics, Inc. (NASDAQ: BBNX) ("Beta Bionics" or the "Company") on behalf of investors who purchased or acquired Beta Bionics securities during the period from July 30, 2025 thro...
Mo., 02.11.2026       Beta Bionics

New York, New York--(Newsfile Corp. - November 2, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. ("Beta Bionics" or the "Company") (NASDAQ: BBNX) on behalf of investors that purchased or otherwise acquired Beta Bionics common stock between July 30, 2025 and February 24, 2026 (...
Mo., 02.11.2026       Beta Bionics

New York, New York--(Newsfile Corp. - November 1, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Beta Bionics, Inc. (NASDAQ: BBNX) between July 30, 2025 and February 24, 2026, both dates inclusive (the "Class Period"), of the important November 3, 2026 lead plaintiff deadline.SO WHAT: If you pu...
So., 01.11.2026       Beta Bionics

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Beta Bionics To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Beta Bionics between July 30, 2025 and February 24, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi...
Silent Ad
So., 01.11.2026       Beta Bionics

New York, New York--(Newsfile Corp. - October 31, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Beta Bionics, Inc. (NASDAQ: BBNX) between July 30, 2025 and February 24, 2026, both dates inclusive (the "Class Period"), of the important November 3, 2026 lead plaintiff deadline.SO WHAT: If y...
Sa., 31.10.2026       Beta Bionics

Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until November 3, 2026 to file lead plaintiff applications in a securities class action lawsuit against Beta Bionics, Inc. (“Beta Bionics” or the “Company”) (NasdaqGM: BBNX), if they purchased or otherw...
Fr., 30.10.2026       Beta Bionics

New York, New York--(Newsfile Corp. - October 30, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Beta Bionics, Inc. (NASDAQ: BBNX) between July 30, 2025 and February 24, 2026, both dates inclusive (the "Class Period"), of the important November 3, 2026 lead plaintiff deadline.SO WHAT: If y...
Fr., 30.10.2026       Beta Bionics

SAN FRANCISCO, Oct. 30, 2026 /PRNewswire/ -- Hagens Berman reminds investors in Beta Bionics, Inc. (NASDAQ: BBNX) of the pending securities class action lawsuit and upcoming November 3, 2026 lead plaintiff deadline under the Private Securities Litigation Reform Act (PSLRA). Investors...
Fr., 30.10.2026       Beta Bionics

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Beta Bionics To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Beta Bionics between July 30, 2025 and February 24, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi...
Fr., 30.10.2026       Beta Bionics

Philadelphia, Pennsylvania--(Newsfile Corp. - October 30, 2026) - Berger Montague PC, a leading national plaintiffs' law firm, announces a class action lawsuit against Beta Bionics, Inc. (NASDAQ: BBNX) ("Beta Bionics" or the "Company") on behalf of investors who purchased or acquired Beta Bionics securities during the period from July 30, 2025 thro...
Fr., 30.10.2026       Beta Bionics

New York, New York--(Newsfile Corp. - October 30, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. ("Beta Bionics" or the "Company") (NASDAQ: BBNX) on behalf of investors that purchased or otherwise acquired Beta Bionics common stock between July 30, 2025 and February 24, 2026 (...
Fr., 30.10.2026       Beta Bionics

NEW YORK, Oct. 29, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Beta Bionics, Inc. (NASDAQ: BBNX) between July 30, 2025 and February 24, 2026, both dates inclusive (the "Class Period"), of the important November 3,...
Do., 29.10.2026       Beta Bionics

Boston, Massachusetts--(Newsfile Corp. - October 29, 2026) - Block & Leviton reminds investors that a securities fraud lawsuit has been filed against Beta Bionics, Inc. (NASDAQ: BBNX) and certain of its executives. Investors who have lost money in their Beta Bionics, Inc. investment should contact the firm to learn more about how they might rec...
Do., 29.10.2026       Beta Bionics

Disclosure under scrutiny: the lawsuit contends Beta Bionics' SEC filings described the FDA's Warning Letter as flagging "non-conformities" in its Quality Management System while allegedly omitting that hundreds of unreported iLet complaints involved life-threatening hypoglycemia.NEW YORK, Oct. 29, 2026 /PRNewswire/ -- SueWallSt notifies investors...
Silent Ad
Do., 29.10.2026       Beta Bionics

NEW YORK, Oct. 29, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. ("Beta Bionics" or the "Company") (NASDAQ: BBNX).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail...
Do., 29.10.2026       Beta Bionics

SAN FRANCISCO, Oct. 29, 2026 /PRNewswire/ -- Hagens Berman reminds investors in Beta Bionics, Inc. (NASDAQ: BBNX) of the pending securities class action lawsuit and upcoming November 3, 2026 lead plaintiff deadline under the Private Securities Litigation Reform Act (PSLRA). Investors...
Do., 29.10.2026       Beta Bionics

A securities fraud class action lawsuit has been filed on behalf of Beta Bionics investors after its stock plummeted over 37% because Beta Bionics allegedly misled investors about the safety, efficacy, and commercial success of its iLet medical device, potentially violating the federal securities laws.New York, New York--(Newsfile Corp. - October 2...
Do., 29.10.2026       Beta Bionics

New York, New York--(Newsfile Corp. - October 29, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. ("Beta Bionics" or the "Company") (NASDAQ: BBNX) on behalf of investors that purchased or otherwise acquired Beta Bionics common stock between July 30, 2025 and February 24, 2026 (...
Mi., 28.10.2026       Beta Bionics

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Beta Bionics To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Beta Bionics between July 30, 2025 and February 24, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi...
Mi., 28.10.2026       Beta Bionics

SAN DIEGO, Oct. 28, 2026 /PRNewswire/ -- Johnson Fistel, PLLP, a shareholder-rights law firm, announces that a securities class action lawsuit has been filed in the United States District Court for the Central District of California on behalf of investors who purchased or otherwise acquired Beta Bionics, Inc. (NASDAQ: BBNX) common stock between Ju...
Mi., 28.10.2026       Beta Bionics

Wall Street stayed constructive on BBNX even after the FDA Warning Letter surfaced, with Leerink writing on January 30, 2026 that management "highlighted there have been no new issues" and Truist stating on February 17, 2026 that the letter was "not on the safety or performance of the company's insulin pump itself." A securities class action alleg...
Mi., 28.10.2026       Beta Bionics

Complaint alleges Beta Bionics, Inc. misled investors between July 30, 2025 and February 24, 2026; investors may seek lead plaintiff role by November 3, 2026LOS ANGELES, Oct. 28, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP ("Glancy") announced today that the class action lawsuit covers investors who bought Beta Bionics, Inc. ("Beta...
Mi., 28.10.2026       Beta Bionics

Philadelphia, Pennsylvania--(Newsfile Corp. - October 28, 2026) - Berger Montague PC, a leading national plaintiffs' law firm, announces a class action lawsuit against Beta Bionics, Inc. (NASDAQ: BBNX) ("Beta Bionics" or the "Company") on behalf of investors who purchased or acquired Beta Bionics securities during the period from July 30, 2025 thro...
Mi., 28.10.2026       Beta Bionics

New York, New York--(Newsfile Corp. - October 28, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Beta Bionics, Inc. (NASDAQ: BBNX) between July 30, 2025 and February 24, 2026, both dates inclusive (the "Class Period"), of the important November 3, 2026 lead plaintiff deadline.SO WHAT: If y...
Mi., 28.10.2026       Beta Bionics

New York, New York--(Newsfile Corp. - October 28, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. ("Beta Bionics" or the "Company") (NASDAQ: BBNX) on behalf of investors that purchased or otherwise acquired Beta Bionics common stock between July 30, 2025 and February 24, 2026 (...
Di., 27.10.2026       Beta Bionics

San Francisco, California--(Newsfile Corp. - October 27, 2026) - Hagens Berman reminds investors in Beta Bionics, Inc. (NASDAQ: BBNX) of the pending securities class action lawsuit and upcoming November 3, 2026 lead plaintiff deadline under the Private Securities Litigation Reform Act (PSLRA).Investors who suffered substantial losses purchasing Bet...
Di., 27.10.2026       Beta Bionics

IRVINE, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results for the quarter ended September 30, 2026 and updated its full year guidance for the year ending December 31, 2026....
Di., 27.10.2026       Beta Bionics

Suit alleges Beta Bionics, Inc. failed to disclose key facts to investors from July 30, 2025 through February 24, 2026; lead plaintiff deadline is November 3, 2026BENSALEM TOWNSHIP, Pa., Oct. 27, 2026 /PRNewswire/ -- The Law Offices of Howard G. Smith today reported that a securities class action lawsuit is pending against Beta Bionics, Inc. ("Bet...
Di., 27.10.2026       Beta Bionics

New York, New York--(Newsfile Corp. - October 27, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Beta Bionics, Inc. (NASDAQ: BBNX) between July 30, 2025 and February 24, 2026, both dates inclusive (the "Class Period"), of the important November 3, 2026 lead plaintiff deadline.SO WHAT: If y...
Di., 27.10.2026       Beta Bionics

Philadelphia, Pennsylvania--(Newsfile Corp. - October 27, 2026) - Berger Montague PC, a leading national plaintiffs' law firm, announces a class action lawsuit against Beta Bionics, Inc. (NASDAQ: BBNX) ("Beta Bionics" or the "Company") on behalf of investors who purchased or acquired Beta Bionics securities during the period from July 30, 2025 thro...
Di., 27.10.2026       Beta Bionics

A securities fraud class action lawsuit has been filed on behalf of Beta Bionics investors after its stock plummeted over 37% because Beta Bionics allegedly misled investors about the safety, efficacy, and commercial success of its iLet medical device, potentially violating the federal securities laws.NEW YORK, Oct. 27, 2026 /PRNewswire/ -- Leadin...
Di., 27.10.2026       Beta Bionics

New York, New York--(Newsfile Corp. - October 27, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. ("Beta Bionics" or the "Company") (NASDAQ: BBNX) on behalf of investors that purchased or otherwise acquired Beta Bionics common stock between July 30, 2025 and February 24, 2026 (...
Di., 27.10.2026       Beta Bionics

NEW YORK, Oct. 27, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Beta Bionics, Inc. ("Beta Bionics" or "the Company") (NASDAQ: BBNX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholde...
Mo., 26.10.2026       Beta Bionics

Boston, Massachusetts--(Newsfile Corp. - October 26, 2026) - Block & Leviton reminds investors that a securities fraud lawsuit has been filed against Beta Bionics, Inc. (NASDAQ: BBNX) and certain of its executives. Investors who have lost money in their Beta Bionics, Inc. investment should contact the firm to learn more about how they might rec...
Mo., 26.10.2026       Beta Bionics

Lawsuit alleges Beta Bionics, Inc. made misleading statements to investors from July 30, 2025 to February 24, 2026; lead plaintiff motions are due November 3, 2026LOS ANGELES, Oct. 26, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz today announced a class action lawsuit against Beta Bionics, Inc. ("Beta Bionics" or the "Company") (NASDAQ: B...
Mo., 26.10.2026       Beta Bionics

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Beta Bionics To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Beta Bionics between July 30, 2025 and February 24, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi...
Mo., 26.10.2026       Beta Bionics

SAN FRANCISCO, Oct. 26, 2026 /PRNewswire/ -- Beta Bionics, Inc. (NASDAQ: BBNX) faces a securities class action, which seeks to represent investors who purchased or otherwise acquired shares of the company's common stock between July 30, 2025 and February 24, 2026. The lawsuit follows...
Mo., 26.10.2026       Beta Bionics

New York, New York--(Newsfile Corp. - October 26, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Beta Bionics, Inc. (NASDAQ: BBNX) between July 30, 2025 and February 24, 2026, both dates inclusive (the "Class Period"), of the important November 3, 2026 lead plaintiff deadline.SO WHAT: If y...
Mo., 26.10.2026       Beta Bionics

New York, New York--(Newsfile Corp. - October 26, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. ("Beta Bionics" or the "Company") (NASDAQ: BBNX) on behalf of investors that purchased or otherwise acquired Beta Bionics common stock between July 30, 2025 and February 24, 2026 (...
Mo., 26.10.2026       Beta Bionics

LOS ANGELES, Oct. 26, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP, a national shareholder rights litigation firm, announces that it has filed a federal securities class action on behalf of purchasers of Beta Bionics, Inc. ("Beta Bionics" or "the Company") (NASDAQ: BBNX) common stock between July 30, 2025 and February 24, 2026, inclusive...
So., 25.10.2026       Beta Bionics

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Beta Bionics To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Beta Bionics between July 30, 2025 and February 24, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi...
So., 25.10.2026       Beta Bionics

New York, New York--(Newsfile Corp. - October 25, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Beta Bionics, Inc. (NASDAQ: BBNX) between July 30, 2025 and February 24, 2026, both dates inclusive (the "Class Period"), of the important November 3, 2026 lead plaintiff deadline.SO WHAT: If y...
Sa., 24.10.2026       Beta Bionics

NEW YORK, Oct. 24, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Beta Bionics, Inc. (NASDAQ: BBNX) between July 30, 2025 and February 24, 2026, both dates inclusive (the "Class Period"), of the important November 3,...
Sa., 24.10.2026       Beta Bionics

A securities fraud class action lawsuit has been filed on behalf of Beta Bionics investors after its stock plummeted over 37% because Beta Bionics allegedly misled investors about the safety, efficacy, and commercial success of its iLet medical device, potentially violating the federal securities laws.New York, New York--(Newsfile Corp. - October 2...